Article thumbnail

Obsessive-compulsive spectrum disorders

By Andrea Allen, Audrey King and Eric Hollander

Abstract

The obsessive-compulsive spectrum is an important concept referring to a number of disorders drawn from several diagnostic categories that share core obsessive-compulsive features. These disorders can be grouped by the focus of their symptoms: bodily preoccupation, impulse control, or neurological disorders. Although the disorders are clearly distinct from one another, they have intriguing similarities in phenomenology, etiology, pathophysiology, patient characteristics, and treatment response. In combination with the knowledge gained through many years of research on obsessive-compulsive disorder (OCD), the concept of a spectrum has generated much fruitful research on the spectrum disorders. It has become apparent that these disorders can also be viewed as being on a continuum of compulsivity to impulsivity, characterized by harm avoidance at the compulsive end and risk seeking at the impulsive end. The compulsive and impulsive disorders differ in systematic ways that are just beginning to be understood. Here, we review these concepts and several representative obsessive-compulsive spectrum disorders including both compulsive and impulsive disorders, as well as the three different symptom clusters: OCD, body dysmorphic disorder, pathological gambling, sexual compulsivity, and autism spectrum disorders

Topics: Clinical Research
Publisher: Les Laboratoires Servier
OAI identifier: oai:pubmedcentral.nih.gov:3181632
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. A 25-year follow-up of cognitive/behavioral therapy with 7275 sexual offenders. Behav Modif.
  2. (1994). A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull.
  3. (1996). A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: a retrospective study. Bull Am Acad Psychiatry Law.
  4. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
  5. (1991). A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry.
  6. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.
  7. (1993). A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. Eur Neuropsychopharmacol.
  8. (2000). A doubleblind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry.
  9. (1994). A meta-analysis on the treatment of obsessive-compulsive disorder: a comparison of antidepressants, behavior, and cognitive therapy. Clin Psychol Rev.
  10. (1994). A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry.
  11. A preliminary consideration of cue-exposure, response-prevention treatment for pathological gambling behavior: two case studies.
  12. A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Res.
  13. A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biol Psychiatry.
  14. (2002). A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry.
  15. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
  16. Abnormal regional cerebral blood flow in childhood autism.
  17. (2003). Acute and long-term treatment and prevention of relapse of obsessivecompulsive disorder with paroxetine. J Clin Psychiatry.
  18. Aizley HG. The DSM-IIIR impulse control disorders not elsewhere classified: clinical characteristics and relationship to other psychiatric disorders.
  19. (1997). Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol.
  20. An open-label study of citalopram in the treatment of pathological gambling.
  21. (1984). An outcome study of an in-patient treatment program for pathological gambling. Hosp Commun Psychiatry.
  22. An update on obsessive-compulsive disorder.
  23. Anxiety in high-functioning children with autism.
  24. (1999). Are sex offenders treatable? A research overview. Psychiatr Serv.
  25. Assessing the prevalence of body dysmorphic disorder in an ethnically diverse group of adolescents.
  26. (2000). Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, Text Revision.
  27. (1998). Autism, affective and other psychiatric disorders: patterns of familial aggregation. Psychol Med.
  28. Autistic traits in obsessive-compulsive disorder.
  29. (2003). Available at: http://www.norc.uchicago.edu/new/gamb-fin.htm.
  30. Aversion therapy for compulsive gamblers.
  31. Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: a quantitative review.
  32. (1998). Behavioral versus pharmacological treatments of obsessive-compulsive disorder: a meta-analysis.
  33. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive-compulsive disorder.
  34. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder.
  35. (1995). Body dysmorphic disorder, pathological gambling and sexual compulsions. J Clin Psychiatry.
  36. (1996). Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial. Behav Res Ther.
  37. (1997). Body dysmorphic disorder: a preliminary evaluation of treatment and maintenance using exposure with response prevention. Behav Res Ther.
  38. (1995). Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? J Clin Psychiatry.
  39. (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry.
  40. Characteristics of 36 subjects reporting compulsive sexual behavior.
  41. Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex.
  42. (2001). Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder. Int Clin Psychopharmacol.
  43. (1999). Citalopram for treatmentresistant obsessive-compulsive disorder. Eur Psychiatry.
  44. Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder.
  45. (1991). Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry.
  46. (1999). Clomipramine vs desipramine crossover trial in body dysmorphic disorder. Arch Gen Psychiatry.
  47. Cognitive and behavioral treatment of pathological gambling: a controlled study.
  48. (1999). Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behav Res Ther.
  49. (1990). Cognitive behavior therapy with and without size perception training for women with body image disturbance. Behav Ther.
  50. (2003). Cognitive treatment of pathological gamblers. Behav Res Ther. 1998;36:1111-1119.Obsessive-compulsive spectrum disorder - Allen et al
  51. (1995). Cognitive-behavioral body image therapy for body dysmorphic disorder.
  52. (1979). Comparative study of prophylactic lithium and diethylstilbestrol in sexual deviants. Act Nerv Super
  53. Comparison of imaginal desensitisation with other behavioural treatments of pathological gambling. A 2- to 9-year follow-up.
  54. (2001). Counting the cost: estimating the economic benefit of pedophile treatment programs. Child Abuse Negl.
  55. Current and experimental therapeutics of obsessive-compulsive disorder.
  56. Current issues in the pharmacologic management of obsessive compulsive disorder.
  57. Delayed maturation of the frontal cortex in childhood autism.
  58. Delusions of parasitosis. A psychiatric disorder to be treated by dermatologists? An analysis of 33 patients.
  59. (2003). Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry. 2002;59:250-261.Obsessive-compulsive spectrum disorder - Allen et al
  60. Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism.
  61. (1998). Does cognitive-behavioral therapy cure obsessive-compulsive disorder? A meta-analytic evaluation of clinical significance. Behav Ther.
  62. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.
  63. (1995). Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry.
  64. (1998). Drug treatment of obsessive-compulsive disorders.
  65. DSM-III obsessive-compulsive disorder: clinical characteristics and family history.
  66. (1995). DSM-IV field trial: obsessive-compulsive disorder.
  67. Effectiveness of pharmacotherapy for body dysmorphic disorder: a chartreview study.
  68. Efficacy of drug treatment in obsessive-compulsive disorder: a meta-analytic review.
  69. (1989). Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry.
  70. Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder.
  71. Evidence for susceptibility for autism on chromosome 2 and for genetic heterogeneity.
  72. Evidence supporting WNT2 as an autism susceptibility gene.
  73. (1997). Expert Consensus Panel for Obsessive-Compulsive Disorder. Treatment of obsessive-compulsive disorder. J Clin Psychiatry.
  74. Five exhibitionists and a method of treatment.
  75. (1992). Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men.
  76. (1993). fluoxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: a meta-analysis. J Behav Ther Exp Psychiatry.
  77. Follow-up of pathological gamblers after treatment.
  78. (1969). Follow-up studies in obsessive neurosis. Arch Gen Psychiatry.
  79. Functional neuroimaging and childhood autism. Pediatr Radiol.
  80. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder.
  81. Gambling and related mental disorders: a public health analysis. Annu Rev Public Health.
  82. Gambling participation in the US—results from a national survey.
  83. (1997). Gender differences in body dysmorphic disorder.
  84. Gender differences in pathological gamblers seeking medication treatment. Compr Psychiatry.
  85. (1981). Group psychotherapy with pathological gamblers.
  86. (1994). Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. Arch Gen Psychiatry.
  87. (1992). Is your patient suffering from compulsive sexual behavior? Psychiat Ann.
  88. Lithium and lady luck; use of lithium carbonate in compulsive gambling.
  89. Lithium and valproate treatment of pathological gambling: a randomized single-blind study.
  90. (1994). Managing the patient with treatment-resistant obsessive-compulsive disorder: current strategies. J Clin Psychiatry.
  91. (1966). Modification of expectations in cases with obsessional rituals. Behav Res Ther.
  92. (1978). Monosymptomatic hypochondriacal psychosis manifesting as delusions of parasitosis: a description of four cases successfully treated with pimozide. Arch Dermatol.
  93. Motivational enhancement and self-help treatments for problem gambling.
  94. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
  95. Neurobiology of the obsessive-compulsive spectrum disorders. Biol Psychiatry.
  96. Neuroimaging in obsessive-compulsive disorder: seeking the mediating neuroanatomy.
  97. Neuroimaging of OCD and related disorders.
  98. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.
  99. (1995). Obsessive-compulsive spectrum disorders. J Clin Psychiatry.
  100. (2000). Obsessive-compulsive spectrum: a review.
  101. (1999). Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series. J Clin Psychiatry.
  102. Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder.
  103. (2000). Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial. Psychiatry Res.
  104. Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.
  105. (2002). Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment. Eur Psychiatry.
  106. Paradoxical intention in the treatment of compulsive gambling.
  107. (1992). Paraphilias: a double-blind crossover comparison of clomipramine versus desipramine. Arch Sex Behav.
  108. Pathological gambling: a review of the literature.
  109. (1992). Pathological gambling. Psychiatr Ann.
  110. (1978). Pharmacological treatment of deviant sexual behaviour. Act Nerv Super
  111. (2000). Pharmacotherapy for obsessive-compulsive disorder. Psychiatr Clin North Am.
  112. (1992). Pharmacotherapy of obsessive compulsive disorder. J Clin Psychiatry.
  113. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo-controlled trial.
  114. (1992). Prevalence of body dysmorphic disorder in non-clinical populations. Paper presented at the meeting of the Association for Advancement of Behavior Therapy,
  115. (1997). Previous SRI treatment and efficacy of sertraline for OCD: combined analysis of 4 multicenter trials. Poster presented at the 150th Annual Meeting of the American Psychiatric Association,
  116. (1991). Psychiatric disorders in the parents of autistic individuals.
  117. Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: a case series.
  118. Refining prevalence estimates of pathological gambling.
  119. Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.
  120. (1993). response prevention, and cognitive therapy in the treatment of body dysmorphic disorder. J Behav Ther Exp Psychiatry.
  121. (1990). Results of a double-blind placebo-controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull.
  122. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
  123. (2003). Risperidone augmentation in SRI-resistant OCD: a preliminary double-blind, placebo controlled study.
  124. (1996). Screening for body dysmorphic disorder in an outpatient clinic.
  125. (1992). Serious juvenile sex offenders: treatment and long-term follow-up. Psychiatr Ann.
  126. (1992). Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.
  127. (1995). Sertraline in the treatment of pedophilia: an open-label study. Presented at the 148th Annual Meeting of the American Psychiatric Association.
  128. (1994). Sertraline pharmacotherapy for paraphilias and paraphiliarelated disorders: an open trial. Ann Clin Psychiatry.
  129. (1998). Sexual addiction: many conceptions, minimal data. Clin Psychol Rev.
  130. (1997). Sexual addiction. In: Lowinson JH,
  131. Short-term single-blind fluvoxamine treatment of pathological gambling.
  132. (1980). Six-month prevalence of psychiatric disorders in three communities
  133. (1990). Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry.
  134. Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men.
  135. Temporal lobe dysfunction in childhood autism: a PET study.
  136. (1994). The cross-national epidemiology of obsessive-compulsive disorder. J Clin Psychiatry.
  137. (1985). The effectiveness of Gamblers Anonymous.
  138. The epidemiology and cross-national presentation of obsessive-compulsive disorder.
  139. (1999). The epidemiology of autism: a review. Psychol Med.
  140. (1998). The obsessive shadow. Professional Counselor.
  141. The obsessive-compulsive spectrums.
  142. (1976). The treatment of compulsive gamblers at the Cleveland VA Hospital, Brecksville Division.
  143. Treatment of a compulsive horse race gambler by aversion therapy.
  144. (1989). Treatment of childhood obsessive-compulsive disorder with clomipramine and desipramine: a doubleblind crossover comparison. Arch Gen Psychiatry.
  145. Treatment of compulsive gamblers using electrical aversion.
  146. Treatment of obsessive-compulsive spectrum disorders with SSRIs.
  147. Treatment of pathological gambling with carbamazepine.
  148. Treatment of poker-machine addicts by aversion therapy.
  149. Venlafaxine in treatment-resistant obsessive-compulsive disorder.
  150. (1985). When Luck Runs Out.